天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

1-(4-Thio-beta-D-ribofuranosyl)cytosine

1-(4-Thio-beta-D-ribofuranosyl)cytosine Struktur
93080-09-2
CAS-Nr.
93080-09-2
Englisch Name:
1-(4-Thio-beta-D-ribofuranosyl)cytosine
Synonyma:
4'-Thiocytidine;Cytidine, 4'-thio-;1-(4-Thio-beta-D-ribofuranosyl)cytosine;4’-Thiocytidine 1-(4-Thio-beta-D-ribofuranosyl)cytosine
CBNumber:
CB22719629
Summenformel:
C9H13N3O4S
Molgewicht:
259.28
MOL-Datei:
93080-09-2.mol

1-(4-Thio-beta-D-ribofuranosyl)cytosine Eigenschaften

Sicherheit

1-(4-Thio-beta-D-ribofuranosyl)cytosine Chemische Eigenschaften,Einsatz,Produktion Methoden

1-(4-Thio-beta-D-ribofuranosyl)cytosine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-(4-Thio-beta-D-ribofuranosyl)cytosine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 25)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19552 58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289
contact@trustwe.com China 5738 58
Changzhou Guiding Bio-Tech. Co.,Ltd.
+86-519-519-86686860 +8618795626222
ning@guiding-bio.com China 299 58
NewCan Biotech Limited
+86-0571-86912261 +8613735419629
sales@newcanbio.com China 9985 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49734 58
TargetMol Chemicals Inc.

support@targetmol.com United States 38630 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131957 58
Chongqing Chemieliva Pharmaceutical Co., Ltd. 023-67770219
jessica.hu@chemieliva.com China 1479 60
T&W GROUP 021-61551611 13296011611
contact@trustwe.com China 9895 58
Zhengzhou Alfachem Co., Ltd. 0371-53765687 18937137882
2853979813@qq.com China 7959 55

93080-09-2()Verwandte Suche:


  • 1-(4-Thio-beta-D-ribofuranosyl)cytosine
  • 4'-Thiocytidine
  • Cytidine, 4'-thio-
  • 4’-Thiocytidine 1-(4-Thio-beta-D-ribofuranosyl)cytosine
  • 93080-09-2
Copyright 2019 ? ChemicalBook. All rights reserved